Cefixime
Cefixime is a third-generation cephalosporin antibiotic used to treat bacterial infections caused by susceptible microorganisms, including uncomplicated urinary tract infections, pharyngitis, tonsillitis and certain respiratory tract infections. It works by inhibiting bacterial cell-wall synthesis, leading to bacterial death. Cefixime is available as oral tablets, capsules and liquid suspensions, depending on the product and market. Common side effects include diarrhoea, nausea, abdominal pain, loose stools and vomiting. Serious risks include severe allergic reactions and antibiotic-associated colitis. Caution is required in patients with a history of cephalosporin or penicillin allergy and in those with impaired kidney function, where dose adjustment may be necessary. Cefixime should be used under medical supervision and only for appropriate bacterial infections to help limit antibiotic resistance.
Cefixime was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Cefixime, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Cefixime from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Cefixime, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
